Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00196404 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
A Phase 2 study of Urinary Incontinence, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 800
- Enrollment target
- 20
- Study locations
NCT00196404 is a Phase 2 study of Urinary Incontinence that has completed, run by Duramed Research. The registered enrollment target is 800 participants, above the 245-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (227% higher). The trial reports 20 study locations across 10 states.
The verdict
NCT00196404, a Phase 2 study of Urinary Incontinence, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 800 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a placebo-controlled, double-blind study to evaluate the safety and efficacy of two doses of DR-3001 in women with overactive bladder who have symptoms of predominant or pure urge incontinence, urinary urgency and elevated urinary frequency
Conditions Studied
Interventions
- OTHER Placebo
- DRUG DR-3001a
- DRUG DR-3001b
Study Locations (20)
Alabama
- Duramed Investigational Site - Birmingham
- Duramed Investigational Site - Huntsville
- Duramed Investigational Site - Mobile
Colorado
- Duramed Investigational Site - Aurora
- Duramed Research Site - Colorado Springs
- Duramed Investigational Site - Denver
Indiana
- Duramed Investigational Site - Boise
- Duramed Investigational Site - Evansville
- Duramed Investigational Site - Fort Wayne
Arizona
- Duramed Research Site - Phoenix
- Duramed Research Site - Tucson
California
- Duramed Investigational Site - San Diego
- Duremed Research Site - San Diego
Florida
- Duramed Investigational Site - Aventura
- Duramed Research Site - Gainesville
Georgia
- Duramed Investigational Site - Decatur
- Duramed Research Site - Sandy Springs
Arkansas
- Duramed Investigational Site - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2004-10 |
| Est. Completion | 2006-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00196404
The ClinicalTrials.gov registry entry for NCT00196404 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 245-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (227% higher). The listed sponsor is Duramed Research, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00196404 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Alabama, Colorado, Indiana.
Frequently Asked Questions
What is clinical trial NCT00196404 about?
NCT00196404 is a clinical study titled "Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder". This is a placebo-controlled, double-blind study to evaluate the safety and efficacy of two doses of DR-3001 in women with overactive bladder who have symptoms of predominant or pure urge incontinence, urinary urgency and elevated urinary frequency
What is the current status of trial NCT00196404?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 800 participants. The study started on 2004-10. Estimated completion is 2006-12.
What conditions does trial NCT00196404 study?
This clinical trial studies the following conditions: Urinary Incontinence.
What interventions are being tested in trial NCT00196404?
The interventions under investigation include: Placebo (OTHER), DR-3001a (DRUG), DR-3001b (DRUG).
Who is sponsoring clinical trial NCT00196404?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00196404 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
RECRUITING · Phase 2
-
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
RECRUITING · Phase 2
-
CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
RECRUITING · Phase 2
-
Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence
COMPLETED · Phase 2
-
Urge Incontinence Bladder Overactivity Study
COMPLETED · Phase 2
-
Translating Unique Learning for Incontinence Prevention
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.